| Hep B |
~50–100 reported (esp. neonates) |
~0 in infants unless mother is infected |
≥10 mIU/mL (anti-HBs) |
Aluminum hydroxide, yeast protein |
DNA virus |
Recombinant w/ aluminum |
SIDS, seizures, autoimmune disorders |
~60,000+ (2,000+ deaths) |
Autism correlation (Simpsonwood), liver injury, neurotoxicity |
| MMR |
~50–100 deaths/severe regression |
~0 deaths in healthy U.S. children |
Not routinely checked |
Gelatin, neomycin, human fetal cell lines |
RNA virus |
Live attenuated |
Encephalitis, seizures, autism regression |
~120,000+ (400+ deaths) |
Autism regression (CDC whistleblower - not Wakefield), ITP, gut-brain inflammation |
| Rotavirus |
50–150 infant deaths in reports |
~0 in U.S. with access to hydration |
Not used clinically |
Porcine DNA, aluminum, bovine serum |
RNA virus |
Live oral |
Intussusception, necrotizing enterocolitis, death |
~80,000+ (100+ deaths) |
Bowel obstruction, microbiome disruption |
| DTaP |
100–200 infant deaths/year reported |
~0 from diphtheria or tetanus; few from pertussis |
Not standard |
Aluminum phosphate, formaldehyde, polysorbate 80 |
Bacteria (toxins) |
Inactivated toxoid + adjuvant |
Seizures, encephalopathy, regression, death |
~200,000+ (thousands of deaths) |
Brain injury, developmental regression, epilepsy |
| Hib |
~30–50 infant deaths in VAERS |
~0 deaths in healthy children post-1990 |
Not standard |
Aluminum hydroxide, formaldehyde |
Bacteria |
Conjugate |
Seizures, SIDS, encephalitis |
~40,000+ (500+ deaths) |
Autoimmune activation, allergic sensitization |
| PCV (Prevnar) |
100–300 deaths/year in reports |
~0 in healthy children post-2000 |
Not standardized |
Aluminum phosphate, polysorbate 80 |
Bacteria |
Conjugate w/ adjuvant |
Seizures, apnea, encephalopathy, SIDS |
~90,000+ (hundreds of deaths) |
Asthma association, autoimmunity, gut dysbiosis |
| IPV |
~30–50 deaths/severe AEs in VAERS |
~0 U.S. polio deaths since 1979 |
≥1:8 neutralization titer |
Formaldehyde, 2-phenoxyethanol, neomycin |
RNA virus |
Inactivated virus |
Paralysis, seizures, anaphylaxis |
~40,000+ (100+ deaths) |
GBS, immune suppression, allergies |
| Varicella |
~50–100 deaths or regressions/year |
~0 deaths in healthy children |
≥5 gpELISA units |
MSG, gelatin, neomycin, fetal cells |
DNA virus |
Live attenuated |
Encephalitis, shingles, seizures, death |
~60,000+ (300+ deaths) |
Reactivation as shingles, neurological disorders |
| Hep A |
~30–50 deaths/severe AEs reported |
~0 in healthy children |
≥20 mIU/mL |
Aluminum hydroxide, formaldehyde |
RNA virus |
Inactivated w/ adjuvant |
Autoimmune hepatitis, death, GBS |
~30,000+ (100+ deaths) |
Autoimmune liver, infertility signals |
| Covid 19 |
Hundreds of reported deaths, esp. myocarditis in youth |
~0 in healthy children |
Spike protein IgG (no standard threshold) |
PEG, lipid nanoparticles, mRNA |
RNA virus (engineered) |
Genetic (mRNA) |
Myocarditis, arrhythmia, death, neurological collapse |
~2 million+ (30,000+ deaths globally) |
Myocarditis (especially males), stroke, fertility concern, turbo-cancers |
| RSV (Beyfortus / Abrysvo) |
Initial deaths and apnea cases emerging (2023–24) |
~0 deaths in full-term infants |
Not measured |
Monoclonal antibody, LNPs, polysorbate 80 |
RNA virus |
mAb / Protein Subunit |
Anaphylaxis, apnea, preterm labor (maternal), sudden death |
<5,000 so far (new) |
Apnea, collapse, unknown long-term immune consequences |
| HPV (Guardasil) |
Hundreds of global deaths and collapse cases |
~0 deaths in teens from HPV |
≥20 mMU/mL (L1 VLPs) |
Aluminum (500 mcg), polysorbate 80, yeast |
DNA virus |
Recombinant subunit w/ adjuvant |
POTS, autoimmune paralysis, ovarian failure, death |
~100,000+ (700+ deaths) |
POTS, infertility, neuroimmune collapse, paralysis |
| Meningococcal |
~50–100 deaths or GBS cases reported |
~10–15 meningococcal deaths/year |
No titer used |
Diphtheria toxoid, aluminum, MF59 (Bexsero) |
Bacteria |
Conjugate / Protein Subunit |
Guillain-Barré, death, seizures, myocarditis |
~60,000+ (100+ deaths) |
GBS, autoimmune paralysis, death post-collapse |
| Rabies |
~0–5 deaths/year post-vaccine (mainly after multiple-dose post-exposure series) |
~0 deaths/year in U.S. when exposure is treated; ~1–3 deaths/year in untreated exposures (bats) |
Complete neutralizing antibody titers (≥0.5 IU/mL WHO standard) |
Human albumin, beta-propiolactone, neomycin, thimerosal (older versions) |
RNA virus |
Inactivated virus (post-exposure prophylaxis) |
Neuroinflammation, autoimmune encephalitis, Guillain-Barré, death (rare) |
~6,000+ (tens of severe reports, <100 deaths) |
Possible chronic neurological sequelae, immune complications after repeated doses |
| Tetanus |
~50–100 deaths/year post-Tdap booster (adults/elderly); few isolated pediatric deaths in VAERS |
~0–2 deaths/year in U.S. (primarily elderly or IV drug users) |
No titer required clinically, but ≥0.1 IU/mL considered protective |
Aluminum phosphate, formaldehyde, 2-phenoxyethanol |
Bacteria (Clostridium tetani – neurotoxin) |
Toxoid (inactivated toxin) |
Seizures, encephalopathy, GBS, anaphylaxis, death |
~75,000+ (thousands of severe reactions, 100s of deaths) |
Neurotoxic cumulative burden (especially with boosters), possible link to chronic fatigue syndromes |
| Influenza |
100–300 deaths/year reported post-vaccine (esp. elderly) |
~0 deaths in healthy children or adults under 50 |
≥1:40 hemagglutination inhibition (HI) titer (questionable correlation to immunity) |
Thimerosal (multi-dose), formaldehyde, polysorbate 80, egg protein |
RNA virus |
Inactivated / Recombinant / Live nasal |
Guillain-Barré, seizures, miscarriage, narcolepsy (H1N1), death |
~200,000+ (thousands of deaths, often denied) |
Autoimmunity, fetal loss (2010 study), chronic fatigue, neurological disorders |
| Shingles |
Hundreds of reports of severe AEs and deaths (esp. elderly) |
~0 deaths from shingles; complications rarely fatal |
No antibody correlate of protection established |
Aluminum + QS-21 (AS01B adjuvant), viral glycoproteins |
DNA virus (VZV) |
Recombinant subunit w/ strong adjuvant |
Severe nerve pain, GBS, autoimmune relapse, death |
~50,000+ (hundreds of severe reactions, many elderly) |
Strong immune overactivation, neurological decline in elderly, suspected link to POTS or MS flares |
